A Functional ABCC11 Allele Is Essential in the Biochemical
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Assessment of Antimicrobial Activity of Cerumen (Earwax) and Antibiotics
Microbiology Research 2020; volume 11:8565 Assessment of antimicrobial nation of fatty acid). Another gland i.e. apoc- activity of cerumen (earwax) rine sweat glands release secretion that com- Correspondence: Iffat Naz, Department of bines with the sebum to form cerumen. It Biology, Scientific Unit, Deanship of and antibiotics against picks up discarded cells, ear follicles and Educational Services, Qassim University, pathogenic bacteria isolated may contain dust or other debris, but the Buraidah, 51452, Qassim, Kingdom of Saudi from ear pus samples resulting compound forms earwax or ceru- Arabia (KSA). men.6 Tel.: +966 533897891 E-mail: [email protected] ; There are two different types of geneti- [email protected] Iffat Naz cally determined earwax such as wet type Department of Biology, Scientific Unit, and dry type. The dry type is most common Key words: Ear pus samples; Pathogenic bac- Deanship of Educational Services, in Asians and Native Americans and has a teria; Antibiotics; Cerumen; Antibacterial Qassim University, Buraidah, Qassim, grey brownish colour while the wet type can potency. Kingdom of Saudi Arabia be found in Caucasians and Africians and has a brown or dark colour.7 About 30-50% of Acknowledgements: The author would like to South Asians, Central Asians and Pacific thanks Mr. Jamil & Miss. Javeria (M. Phil islanders have the dry type of cerumen. Scholars), for assisting in collection of ear pus Abstract Cerumen type has been used by anthropolo- samples from different hospitals of Peshawar, gist to track human migratory patterns, such KP, Pakistan. She is also grateful to Dr. Abdul The present study is focused on the Rehman for providing laboratory facilities, at as those of Eskimas.8 Further, the study of assessment of the antimicrobial activity of Department of Microbiology, Abasyn cerumen and antibiotics against bacteria earwax has shown controversy, as some University Peshawar, KP, Pakistan. -
Blueprint Genetics ABCC11 Single Gene Test
ABCC11 single gene test Test code: S02680 Phenotype information Apocrine gland secretion, variation in Alternative gene names MRP8 Test Strengths The strengths of this test include: CAP accredited laboratory CLIA-certified personnel performing clinical testing in a CLIA-certified laboratory Powerful sequencing technologies, advanced target enrichment methods and precision bioinformatics pipelines ensure superior analytical performance Careful construction of clinically effective and scientifically justified gene panels Our Nucleus online portal providing transparent and easy access to quality and performance data at the patient level Our publicly available analytic validation demonstrating complete details of test performance ~2,000 non-coding disease causing variants in our clinical grade NGS assay for panels (please see ‘Non-coding disease causing variants covered by this test’) Our rigorous variant classification scheme Our systematic clinical interpretation workflow using proprietary software enabling accurate and traceable processing of NGS data Our comprehensive clinical statements Test Limitations This test does not detect the following: Complex inversions Gene conversions Balanced translocations Mitochondrial DNA variants Repeat expansion disorders unless specifically mentioned Non-coding variants deeper than ±20 base pairs from exon-intron boundary unless otherwise indicated (please see above non-coding variants covered by the test). This test may not reliably detect the following: Low level mosaicism (variant with a minor allele fraction of 14.6% is detected with 90% probability) Stretches of mononucleotide repeats Indels larger than 50bp Single exon deletions or duplications Variants within pseudogene regions/duplicated segments The sensitivity of this test may be reduced if DNA is extracted by a laboratory other than Blueprint Genetics. For additional information, please refer to the Test performance section and see our Analytic Validation. -
What Causes Swimmer's Ear?
Swimmer’s Ear Affecting the outer ear, swimmer’s ear is a painful condition resulting from inflammation, irritation, or infection. These symptoms often occur after water gets trapped in your ear, with subsequent spread of bacteria or fungal organisms. Because this condition commonly affects swimmers, it is known as swimmer’s ear. Swimmer’s ear (also called acute otitis externa) often affects children and teenagers, but can also affect those with eczema (a condition that causes the skin to itch), or excess earwax. Your doctor will prescribe treatment to reduce your pain and to treat the infection. What causes swimmer’s ear? A common source of the infection is increased moisture trapped in the ear canal, from baths, showers, swimming, or moist environments. When water is trapped in the ear canal, bacteria that normally inhabit the skin and ear canal multiply, causing infection of the ear canal. Swimmer’s ear needs to be treated to reduce pain and eliminate any effect it may have on your hearing, as well as to prevent the spread of infection. Other factors that may contribute to swimmer’s ear include: ● Contact with excessive bacteria that may be present in hot tubs or polluted water ● Excessive cleaning of the ear canal with cotton swabs ● Contact with certain chemicals such as hair spray or hair dye (Avoid this by placing cotton balls in your ears when using these products.) ● Damage to the skin of the ear canal following water irrigation to remove wax ● A cut in the skin of the ear canal ● Other skin conditions affecting the ear canal, such as eczema or seborrhea What are the signs and symptoms? The most common symptoms of swimmer’s ear are itching inside the ear and pain that gets worse when you tug on the auricle (outer ear). -
Association Between the ABCC11 Gene Polymorphism and the Expression of Apolipoprotein D by the Apocrine Glands in Axillary Osmidrosis
MOLECULAR MEDICINE REPORTS 11: 4463-4467, 2015 Association between the ABCC11 gene polymorphism and the expression of apolipoprotein D by the apocrine glands in axillary osmidrosis ZHECHEN ZHU1, HONGWEI ZHANG1, GUANGHUA LUO2, NING XU3 and ZHONGLAN PAN1 1Department of Plastic and Burn Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210003; 2Comprehensive Laboratory, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213003, P.R. China; 3Section of Clinical Chemistry and Pharmacology, Institute of Laboratory Medicine, Lund University, Lund S-221 85, Sweden Received April 1, 2014; Accepted December 9, 2014 DOI: 10.3892/mmr.2015.3274 Abstract. It has been suggested that the adenosine triphos- gene in the mediation of osmidrosis by enhancing the transi- phate-binding cassette sub-family C member 11 (ABCC11) tion of odor precursors via the ApoD pathway. gene polymorphism and apolipoprotein D (ApoD), an odor precursor carrier, may be important in the formation of axil- Introduction lary odor. To date, few studies have examined the potential correlation between these two factors. The present study Osmidrosis is one of the most common complaints in the aimed to investigate the association between a 538 G>A departments of plastic surgery at the First Affiliated Hospital single-nucleotide polymorphism (SNP) of the ABCC11 gene of Nanjing Medical University (Nanjing, China). The apocrine and the mRNA expression levels of ApoD in the apocrine glands, which are located in the axilla, are the predominant gland of patients with osmidrosis. The 538 G>A polymor- cause of axillary odor (1). This is due to the fat-like secretion phism genotypes of 33 patients with a clinical diagnosis of produced by the apocrine glands, which is broken down into osmidrosis were analyzed by polymerase chain reaction (PCR) volatile odorous substances by bacteria (2). -
Supplementary Methods Earwax Sample Extraction a Clinical Research Assistant Was Specifically Trained in the Use of the Reiner-A
Supplementary Methods Earwax Sample Extraction A clinical research assistant was specifically trained in the use of the Reiner-Alexander syringe by one ear-nose-throat specialist doctor. Before cleaning both ears, the external auditory canal was examined using an otoscope to rule out the presence of any external ear pathology, such as impacted earwax or perforated eardrum. Briefly, the Reiner-Alexander syringe slowly injects water at 37°C inside the external ear canal. The process of syringing creates a sensation of mild pressure in the ear as the warm water from the syringe flushes the wax out. The expelled water and the extracted earwax secretion were collected in a kidney basin. During the follow-up visit, participants self-clean their right ears using the earwax self-sampling device, according to the manufacturer instructions (www.trears.com). The four labelled earwax samples were stored at 4 °C until they were analysed. Earwax Analysis using the Reiner-Alexander Syringe The extracted solution of water plus earwax secretion was stored in a 50 ml cryovial. Earwax samples were then resuspended with 500 µl Phosphate-Buffered Saline (PBS) to homogenise the sample. Then, 500 µl of diethyl ether was added to each sample and wobbled for one minute using a vortex. The resulting solution was stored at -20°C for 2 hours. Glucose levels were then analysed from the hydrophilic fraction. The earwax solution was dried using the displacement method of N2 at 25 degree Celsius. Following this, 125 µl of PPBS was added to resuspend each solution. The resulting solution containing earwax samples was stored at 4 degrees Celsius until analysed. -
Transcriptional and Post-Transcriptional Regulation of ATP-Binding Cassette Transporter Expression
Transcriptional and Post-transcriptional Regulation of ATP-binding Cassette Transporter Expression by Aparna Chhibber DISSERTATION Submitted in partial satisfaction of the requirements for the degree of DOCTOR OF PHILOSOPHY in Pharmaceutical Sciences and Pbarmacogenomies in the Copyright 2014 by Aparna Chhibber ii Acknowledgements First and foremost, I would like to thank my advisor, Dr. Deanna Kroetz. More than just a research advisor, Deanna has clearly made it a priority to guide her students to become better scientists, and I am grateful for the countless hours she has spent editing papers, developing presentations, discussing research, and so much more. I would not have made it this far without her support and guidance. My thesis committee has provided valuable advice through the years. Dr. Nadav Ahituv in particular has been a source of support from my first year in the graduate program as my academic advisor, qualifying exam committee chair, and finally thesis committee member. Dr. Kathy Giacomini graciously stepped in as a member of my thesis committee in my 3rd year, and Dr. Steven Brenner provided valuable input as thesis committee member in my 2nd year. My labmates over the past five years have been incredible colleagues and friends. Dr. Svetlana Markova first welcomed me into the lab and taught me numerous laboratory techniques, and has always been willing to act as a sounding board. Michael Martin has been my partner-in-crime in the lab from the beginning, and has made my days in lab fly by. Dr. Yingmei Lui has made the lab run smoothly, and has always been willing to jump in to help me at a moment’s notice. -
P-Glycoprotein Drug Transporters in the Parasitic Nematodes Toxocara Canis and Parascaris
Iowa State University Capstones, Theses and Graduate Theses and Dissertations Dissertations 2019 P-glycoprotein drug transporters in the parasitic nematodes Toxocara canis and Parascaris Jeba Rose Jennifer Jesudoss Chelladurai Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/etd Part of the Parasitology Commons, and the Veterinary Medicine Commons Recommended Citation Jesudoss Chelladurai, Jeba Rose Jennifer, "P-glycoprotein drug transporters in the parasitic nematodes Toxocara canis and Parascaris" (2019). Graduate Theses and Dissertations. 17707. https://lib.dr.iastate.edu/etd/17707 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. P-glycoprotein drug transporters in the parasitic nematodes Toxocara canis and Parascaris by Jeba Rose Jennifer Jesudoss Chelladurai A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Veterinary Pathology (Veterinary Parasitology) Program of Study Committee: Matthew T. Brewer, Major Professor Douglas E. Jones Richard J. Martin Jodi D. Smith Tomislav Jelesijevic The student author, whose presentation of the scholarship herein was approved by the program of study committee, is solely responsible for the content of this dissertation. The Graduate College will ensure this dissertation is globally accessible and will not permit alterations after a degree is conferred. Iowa State University Ames, Iowa 2019 Copyright © Jeba Rose Jennifer Jesudoss Chelladurai, 2019. -
Earwax Problems N
n Earwax Problems n Can earwax problems Earwax, also called cerumen, is a normal sub- stance that helps protect the ear canal. If too be prevented? much earwax builds up, it can block the ear canal, If your child has a lot of earwax build-up, using special causing ear discomfort, reduced hearing, and eardrops on a regular basis may help to prevent prob- other symptoms. Excessive earwax can usually lems. be removed by using special drops. If necessary, it can be done by a doctor. Don’t try to remove Follow the doctor’s instructions on removing earwax. wax from your child’s ear by inserting anything in Especially in babies, never insert cotton swabs or any- the ear, including cotton swabs. thing else in the ear to attempt to remove earwax. How are earwax problems treated? What kinds of problems are caused by earwax? Earwax removal kits are available at drugstores. Tilt your child’s head sideways and then place drops in the ear. Let The build-up of too much earwax can block the your the drops remain in the ear for several minutes; they will child’s ear canal. This is sometimes called “impaction.” help dissolve the wax. This procedure can be repeated for Removing the excessive earwax promptly relieves symp- a few days, if needed. If excessive earwax is still present, toms such as feeling “clogged-up,” reduced hearing, and call our office. discomfort or pain. Earwax can be removed by using ear- ’ drops available at the drugstore or, if necessary, in the In the doctor s office, earwax may be removed using spe- doctor’s office. -
ABCB1 and ABCC11 Confer Resistance to Eribulin in Breast Cancer Cell Lines
www.impactjournals.com/oncotarget/ Oncotarget, Vol. 7, No. 43 Research Paper ABCB1 and ABCC11 confer resistance to eribulin in breast cancer cell lines Takaaki Oba1, Hiroto Izumi2, Ken-ichi Ito1 1Division of Breast, Endocrine and Respiratory Surgery, Department of Surgery (II), Shinshu University School of Medicine, Matsumoto, Japan 2Department of Occupational Pneumology, Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Japan Correspondence to: Ken-ichi Ito, email: [email protected] Keywords: eribulin, drug resistance, breast cancer, ABCB1, ABCC11 Received: May 13, 2016 Accepted: August 09, 2016 Published: August 31, 2016 ABSTRACT This study aimed to elucidate the mechanisms underlying the resistance of breast cancer to eribulin. Seven eribulin-resistant breast cancer cell lines (MCF7/E, BT474/E, ZR75-1/E, SKBR3/E, MDA-MB-231/E, Hs578T/E, and MDA-MB-157/E) were established. mRNA and protein expression of ATP-binding cassette subfamily B member 1 (ABCB1) and subfamily C member 11 (ABCC11) increased in all eribulin-resistant cell lines compared to the parental cell lines. When ABCB1 or ABCC11 expression was inhibited by small interfering RNA in MCF7/E, BT474/E, and MDA-MB-231/E cells, eribulin sensitivity was partially restored. Moreover, eribulin resistance was attenuated additively by inhibiting ABCB1 and ABCC11 in MCF7/E cells. Additionally, overexpression of exogenous ABCB1 or ABCC11 in HEK293T cells conferred resistance to eribulin. MCF7/E and MDA- MB-231/E cells showed cross-resistance to paclitaxel, doxorubicin, and fluorouracil. Inhibition of ABCB1 partially restored paclitaxel and doxorubicin sensitivity. Partial restoration of fluorouracil sensitivity was induced by inhibiting ABCC11 in MCF7/E and MDA-MB-231/E cells. -
Earwax, Clinical Practice Il Tappo Di Cerume: Pratica Clinica F
Volume 29 – Supplement 1 – Number 4 – August 2009 Otorhinolaryngologica Italica Official Journal of the Italian Society of Otorhinolaryngology - Head and Neck Surgery Organo Ufficiale della Società Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale Editorial Board Italian Scientific Board © Copyright 2009 by Editor-in-Chief: F. Chiesa L. Bellussi, G. Danesi, C. Grandi, Società Italiana di Otorinolaringologia e President of S.I.O.: A. Rinaldi Ceroni A. Martini, L. Pignataro, F. Raso, Chirurgia Cervico-Facciale Former Presidents of S.I.O.: R. Speciale, I. Tasca Via Luigi Pigorini, 6/3 G. Borasi, E. Pirodda (†), 00162 Roma, Italy I. De Vincentiis, D. Felisati, L. Coppo, International Scientific Board G. Zaoli, P. Miani, G. Motta, J. Betka, P. Clement, A. De La Cruz, Publisher L. Marcucci, A. Ottaviani, G. Perfumo, M. Halmagyi, L.P. Kowalski, Pacini Editore SpA P. Puxeddu, I. Serafini, M. Maurizi, M. Pais Clemente, J. Shah, Via Gherardesca,1 G. Sperati, D. Passali, E. de Campora, H. Stammberger 56121 Ospedaletto (Pisa), Italy A. Sartoris, P. Laudadio, E. Mora, Tel. +39 050 313011 M. De Benedetto, S. Conticello, D. Casolino Treasurer Fax +39 050 313000 Former Editors-in-Chief: C. Miani [email protected] C. Calearo (†), E. de Campora, www.pacinimedicina.it A. Staffieri, M. Piemonte Editorial Office Editor-in-Chief: F. Chiesa Cited in Index Medicus/MEDLINE, Editorial Staff Divisione di Chirurgia Cervico-Facciale Science Citation Index Expanded, Scopus Editor-in-Chief: F. Chiesa Istituto Europeo di Oncologia Deputy Editor: C. Vicini Via Ripamonti, 435 Associate Editors: 20141 Milano, Italy C. Viti, F. Scasso Tel. +39 02 57489490 Editorial Coordinators: Fax +39 02 57489491 M.G. -
Types of Hearing Loss
Hearing Basics |Alberta Hands & Voices Parent Toolkit Types of Hearing Loss Problems in the outer ear and ear canal can Some types of conductive prevent sound from travelling normally to the hearing loss can be inner ear. This is conductive hearing loss. medically treated. There are many causes of conductive hearing loss. The outer ear may form in an atypical way at birth, closing off the ear to hearing, or the ear canal may be blocked by earwax. Middle ear infections can also cause conductive hearing loss. The space behind the eardrum (the middle ear) is normally air-filled but sometimes with ear infections, fluid can collect there. This build-up of fluid prevents the eardrum from vibrating normally. A conductive hearing loss can also be caused by a hole in the eardrum. Another cause of conductive hearing loss includes damage to the three tiny bones inside the middle ear. Eardrum movement can be tested or measured by sending a puff of air into the ear canal to Most types of vibrate the eardrum (tympanometry). Having a sensorineural hearing loss conductive hearing loss is like wearing are permanent and cannot earplugs: you won’t hear soft sounds. Some be corrected by surgery or types of conductive hearing loss can be medication. medically corrected. In the inner ear, missing or deformed hair cells prevent sound from being sent normally to the brain. A sensorineural hearing loss happens when there are problems with the hair cells. The auditory or hearing nerve starts in the cochlea and travels to the auditory centres of the brain. -
ABCC11 Gene Polymorphism As a Potential Predictive Biomarker for an Oral 5‑Fuorouracil Derivative Drug S‑1 Treatment in Non‑Small Cell Lung Cancer
Cancer Chemotherapy and Pharmacology (2019) 84:1229–1239 https://doi.org/10.1007/s00280-019-03959-3 ORIGINAL ARTICLE ABCC11 gene polymorphism as a potential predictive biomarker for an oral 5‑fuorouracil derivative drug S‑1 treatment in non‑small cell lung cancer Takehiro Uemura1,2 · Tetsuya Oguri3 · Ken Maeno1 · Kazuki Sone1 · Akira Takeuchi1 · Satoshi Fukuda1 · Eiji Kunii4 · Osamu Takakuwa1 · Yoshihiro Kanemitsu1 · Hirotsugu Ohkubo1 · Masaya Takemura1 · Yutaka Ito1 · Akio Niimi1 Received: 11 March 2019 / Accepted: 5 September 2019 / Published online: 17 September 2019 © Springer-Verlag GmbH Germany, part of Springer Nature 2019 Abstract Purpose ABCC11/MRP8 (ABCC11) is an ATP-binding cassette transporter that is involved in regulating cellular sensitiv- ity and resistance for many anti-cancer drugs. Since 5-fuorouracil (5-FU) is one of the substrates for ABCC11, we exam- ined whether ABCC11 is a predictive marker for an oral 5-FU derivative drug S-1 treatment in non-small cell lung cancer (NSCLC). Methods Real-time PCR and MTS assay were carried on 21 human NSCLC cell lines. The drug resistance capabilities of ABCC11 are evaluated by analyzing the resistance profles of a clone of HeLa cell in which the pump was ectopically expressed. Blood samples of 106 NSCLC patients were collected. Results There was a signifcant correlation between dihydropyrimidine dehydrogenase (DPD) gene expression and the IC 50 for 5-FU. We then classifed NSCLC cell lines into two groups based on the phenotype of the SNP538 (G > A) in ABCC11: a combined G/G and G/A group, and an A/A group. The distribution of the IC 50 for 5-FU in combination with a potent inhibitor of DPD 5-chloro-2, 4-dihydropyrimidine (CDHP), which is contained in S-1, showed a signifcant reduction in the A/A group compared with the combined G/G and G/A group.